Enteric-coated aspirin caplets

DRUG2 trials

Sponsors

PLx Pharma

Conditions

Diabetes Mellitus, Type 2

Phase 3

Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated and Immediate Release Aspirin in Diabetic Patients

CompletedNCT01515657

PLx PharmaDiabetes Mellitus, Type 2

Start: 2012-01-31End: 2012-06-30Updated: 2016-03-14

Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated Aspirin in Diabetic Patients

CompletedNCT02008942

PLx PharmaDiabetes Mellitus, Type 2

Start: 2014-01-31End: 2014-04-30Updated: 2016-03-10

Related Papers

Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus.

2017-01-1196 citations